Episode 141.0 – Journal Update
This week we discuss some recent publications relevant to EM: ADRENAL, Idarucizumab and Time to Furosemide.
Show Notes
Read More
Core EM: Idarucizumab for Reversal of Dabigitran
Core EM: Idarucizumab for Reversal of Dabigitran II
First10EM: Idarucizumab: Plenty of Optimism, Not Enough Science
EM Lit of Note: The Door-to-Lasix Quality Measure
EMS MED: When It’s More Complicated Than A Tweet: Door-To-Furosemide And EMS
